Table 1 |
||
|
Conditions and content of brief educational messages attached to test reports. |
||
|
Study phase |
Type and attachment of message |
Content of message |
|
|
||
|
Phase One |
Unconditional; attached to all cholesterol reports |
For type 2 diabetes &age ≥ 40 yrs: on simvastatin 40 mg? See [local guideline] for detail and exclusions |
|
Conditional; attached to all HbA1c reports |
If HbA1c < 6.5% |
|
|
"Within target for type 2 diabetes" |
||
|
If HbA1c 6.5 – 7.0% |
||
|
"For type 2 diabetes, consider increasing oral therapy" |
||
|
If HbA1c 7.0–8.0% |
||
|
"If type 2 diabetes: on max oral therapy, e.g., Metformin 1G BD + gliclazide 160 mg BD?" |
||
|
If HbA1c > 8.0% |
||
|
"If type 2 diabetes, consider insulin if on max oral Rx, e.g., Metformin 1G BD + gliclazide 160 mg BD" |
||
|
Phase Two |
Unconditional; attached to all albumin: creatinine ratio (ACR) test reports |
Newcastle Diabetes Guideline Footcare: all patients annual review of sensation, pulses, footwear education |
|
Conditional; attached to all ACR test reports |
If ACR above 2.5 |
|
|
If confirmed microalbuminuria: aim for BP < 130/80 in type 2 diabetes |
||
|
If ACR below 2.5 |
||
|
If no microalbuminuria: aim for BP control < 140/80 in type 2 diabetes |
||
|
|
||
|
Foy et al. Implementation Science 2007 2:22 doi:10.1186/1748-5908-2-22 |
||